JP2023521722A5 - - Google Patents

Info

Publication number
JP2023521722A5
JP2023521722A5 JP2022561133A JP2022561133A JP2023521722A5 JP 2023521722 A5 JP2023521722 A5 JP 2023521722A5 JP 2022561133 A JP2022561133 A JP 2022561133A JP 2022561133 A JP2022561133 A JP 2022561133A JP 2023521722 A5 JP2023521722 A5 JP 2023521722A5
Authority
JP
Japan
Prior art keywords
composition according
composition
unit
patient
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022561133A
Other languages
English (en)
Japanese (ja)
Other versions
JP7902473B2 (ja
JP2023521722A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/059117 external-priority patent/WO2021204911A1/en
Publication of JP2023521722A publication Critical patent/JP2023521722A/ja
Publication of JP2023521722A5 publication Critical patent/JP2023521722A5/ja
Application granted granted Critical
Publication of JP7902473B2 publication Critical patent/JP7902473B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022561133A 2020-04-07 2021-04-07 Apc標的化単位を用いたネオエピトープ免疫療法 Active JP7902473B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP20168405 2020-04-07
EP20168405.7 2020-04-07
EP20207528.9 2020-11-13
EP20207528 2020-11-13
PCT/EP2021/059117 WO2021204911A1 (en) 2020-04-07 2021-04-07 Neoepitope immunotherapy with apc targeting unit

Publications (3)

Publication Number Publication Date
JP2023521722A JP2023521722A (ja) 2023-05-25
JP2023521722A5 true JP2023521722A5 (cg-RX-API-DMAC10.html) 2024-04-16
JP7902473B2 JP7902473B2 (ja) 2026-08-10

Family

ID=75339769

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022561133A Active JP7902473B2 (ja) 2020-04-07 2021-04-07 Apc標的化単位を用いたネオエピトープ免疫療法

Country Status (7)

Country Link
US (1) US20230147574A1 (cg-RX-API-DMAC10.html)
EP (1) EP4132959A1 (cg-RX-API-DMAC10.html)
JP (1) JP7902473B2 (cg-RX-API-DMAC10.html)
CN (1) CN115698051A (cg-RX-API-DMAC10.html)
AU (1) AU2021253641B2 (cg-RX-API-DMAC10.html)
CA (1) CA3174417A1 (cg-RX-API-DMAC10.html)
WO (1) WO2021204911A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022013277A1 (en) * 2020-07-14 2022-01-20 Evaxion Biotech A/S Apc targeting units for immunotherapy
US20250304626A1 (en) 2021-05-26 2025-10-02 Evaxion Biotech A/S Vaccination targeting intracellular pathogens
WO2023111306A1 (en) 2021-12-17 2023-06-22 Evaxion Biotech A/S Personalized cancer therapy targeting normally non-expressed sequences
WO2024126758A2 (en) * 2022-12-14 2024-06-20 Ultimovacs Ab A nucleic acid molecule and a chimeric polypeptide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2335730A1 (en) * 2009-12-18 2011-06-22 Deutsches Krebsforschungszentrum Fusion polypeptides and their use for prevention and treatment of cancer
WO2011161244A1 (en) * 2010-06-25 2011-12-29 Vaccibody As Homodimeric protein constructs
JP7114477B2 (ja) 2015-12-16 2022-08-08 グリットストーン バイオ インコーポレイテッド 新生抗原の特定、製造、および使用
JP2019505512A (ja) * 2016-01-08 2019-02-28 バッシボディ アクスイェ セルスカプ 治療用抗癌ネオエピトープワクチン
WO2017192924A1 (en) * 2016-05-04 2017-11-09 Fred Hutchinson Cancer Research Center Cell-based neoantigen vaccines and uses thereof
AU2018254526B2 (en) 2017-04-19 2024-02-15 Seattle Project Corp. Neoantigen identification, manufacture, and use
EP3678698A1 (en) * 2017-09-07 2020-07-15 University Of Oslo Vaccine molecules
CN111465989B (zh) 2017-10-10 2024-06-25 磨石生物公司 使用热点进行的新抗原鉴别
AU2018373154B2 (en) 2017-11-22 2025-08-07 Seattle Project Corp. Reducing junction epitope presentation for neoantigens
AU2019215031C1 (en) * 2018-01-31 2026-02-26 Novartis Ag Combination therapy using a chimeric antigen receptor

Similar Documents

Publication Publication Date Title
JP2023533871A5 (cg-RX-API-DMAC10.html)
AU2018203170B2 (en) Multimeric Fusion Protein Vaccine And Immunotherapeutic
CA2687395C (en) Complement factor h-derived short consensus repeat-antibody constructs
RU2677799C2 (ru) Модифицированные суперспиральные белки с улучшенными свойствами
AU2008310313C1 (en) A method of transfection and compositions therefor
JP2022529989A (ja) フラジェリン融合タンパク質及びその使用
RU97118145A (ru) Внутриклеточный домен белка her-2/neu для предупреждения или лечения малигнизаций
WO2001026608A2 (en) Dna vaccines encoding antigen linked to a domain that binds cd40
US11352416B2 (en) Mosaic chimeric viral vaccine particle
US20230355733A1 (en) APC targeting units for immunotherapy
JP2023521722A (ja) Apc標的化単位を用いたネオエピトープ免疫療法
CN118354785A (zh) 靶向催化性补体活化分子及其使用方法
Gor et al. Genetic fusion of three tandem copies of murine C3d sequences to diphtheria toxin fragment B elicits a decreased fragment B-specific antibody response
JP2023546485A (ja) Pd-l1の細胞外ドメインを含むキメラ抗原
CN115197303B (zh) 一种s蛋白的受体结合结构域的突变体及其应用
ES2719256T3 (es) Proteínas de tipo superhélice modificadas que presentan unas propiedades mejoradas
WO2025061682A1 (en) Adenoviral targeting of dendritic cells
CN116457006A (zh) 用于免疫疗法的apc靶向单元